©Author(s) (or their employer(s)) 2026.
World J Clin Pediatr. Mar 9, 2026; 15(1): 111501
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.111501
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.111501
Table 13 Summary of key studies on cesarean section and food allergy risk
| Ref. | Country | Sample size | Follow-up | Association with food allergy | Modifiable factors | Risk of bias |
| Papathoma et al[71], 2016 | Greece | 459 | 3 years | ↑ C-section risk (OR: 3.15); higher with parental atopy | Atopic dermatitis, gestational age | Moderate (small sample, good confounder adjustment) |
| Eggesbø et al[72], 2003 | Norway | 2803 | 2.5 years | ↑ Risk in allergic mothers (OR: 7.0) | Antibiotics not significant | Low (strong prospective design, adjusted) |
| Mitselou et al[73], 2018 | Sweden | 1086378 | 13 years | HR: 1.21 for C-section | LGA, low Apgar score | Low (large population-based cohort) |
| Pyrhönen et al[74], 2022 | Finland | 5564 | 12 years | RR: 2.41 for elective C-section in non-atopic mothers | Sibling atopy modifies risk | Moderate (targeted subgroup, adjusted analysis) |
| Polos and Fletcher[75], 2019 | United States | 150000+ | Cross-sectional | ↑ Food allergy across racial groups | Race, C-section rate, birth cohort effects | Moderate (large dataset, cross-sectional limitations) |
| Currell et al[76], 2022 | Australia | 5276 | 12 months | No association with C-section (aOR: Approximately 1.0) | Labor, feeding, siblings not modifying | Low (clear methodology and control) |
| Chua et al[77], 2025 | Taiwan | > 1 million | Approximately 14 years | No significant food allergy risk (aHR: 1.13) | ↑ Asthma, eczema, obesity | Low (nationwide cohort, adjusted) |
| Tamai et al[78], 2025 | Japan | 2114 | 9 years | No significant association (aRR: 1.1; CI: 0.7-1.7) | Adjusted for child & parental variables | Low (population-based, adjusted with GEE) |
| Adeyeye et al[79], 2019 | United States | Approximately 2900 | 3 years | ↑ Risk with emergency C-section (RR: 3.02) | Breastfeeding (partial mediation) | Moderate (good adjustment, moderate size) |
| Yang M et al[80], 2019 | China | 6768 | 12 months | ↑ C-section and formula feeding in CMPA group | High tolerance after 1 year (77%) | Moderate (well-documented, short-term) |
| Gil et al[81], 2017 | Spain | 211 cases + controls | Retrospective | C-section + formula (FFH) ↑ risk (OR: 11.82) | FFH and breastfeeding key risk factors | Moderate (case-control, smaller scale) |
| Metsälä et al[82], 2010 | Finland | 16237 CMPA cases | 2 years | C-section (OR: 1.18); high maternal age ↑ risk | Smoking & low SES ↓ risk | Low (large birth cohort, adjusted) |
| Toro Monjaraz et al[83], 2015 | Mexico | 101 CMPA, 90 controls | Retrospective | No C-section effect; antibiotics ↑ risk | Breastfeeding duration ↓ risk | High (small sample, retrospective) |
| Kuitunen et al[84], 2009 | Finland | 1018 | 5 years | Probiotics ↓ allergy in C-section-born infants | Perinatal probiotic supplementation | Moderate (well-executed trial, modest size) |
- Citation: Al-Beltagi M, Alzayani S, Saeed NK, Bediwy AS, Prabu Kumar A, Bediwy HA, Elbeltagi R. Gastrointestinal consequences of cesarean section birth: A systematic review of short- and long-term effects in infancy and beyond. World J Clin Pediatr 2026; 15(1): 111501
- URL: https://www.wjgnet.com/2219-2808/full/v15/i1/111501.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v15.i1.111501